Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors.

Lazow, Margot A; Fuller, Christine; Trout, Andrew T; Stanek, Joseph R; Reuss, Jaime; Turpin, Brian K; Szabo, Sara; Salloum, Ralph

Lazow, Margot A; Fuller, Christine; Trout, Andrew T; Stanek, Joseph R; Reuss, Jaime; Turpin, Brian K; Szabo, Sara; Salloum, Ralph.

Afiliação

Lazow MA; Pediatric Neuro-Oncology Program, Nationwide Children's Hospital, Columbus, OH, United States.
Fuller C; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, United States.
Trout AT; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Stanek JR; Department of Pathology, Upstate Medical University, Syracuse, NY, United States.
Reuss J; Department of Radiology and Medical Imaging, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Turpin BK; Department of Radiology, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
Szabo S; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
Salloum R; Pediatric Neuro-Oncology Program, Nationwide Children's Hospital, Columbus, OH, United States.

Front Oncol ; 12: 996489, 2022.

Article em En | MEDLINE | ID: mdl-36465400

Palavras-chave

DOTATATE; SST2A; embryonal tumors; immunohistochemistry; medulloblastoma; pediatric CNS tumors; somatostatin receptor; somatostatin receptor-targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google